Wasvary, M J <br/><br/>
Identification of potential antiatherosclerotic/hypolipidemic agents by their effect on hepatic conversion of androst-4-ene-3,17-dione to etiocholanolone and androsterone.  [electronic resource] 

 -  Atherosclerosis  Jan 1985 
 - 23-36 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0021-9150 
<br/><br/><label>Standard No.: </label>10.1016/0021-9150(85)90150-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3-Hydroxysteroid Dehydrogenases--metabolism<br/>3-Oxo-5-alpha-Steroid 4-Dehydrogenase--metabolism<br/>3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)<br/>Androstenedione--metabolism<br/>Androsterone--biosynthesis<br/>Animals<br/>Arteriosclerosis--drug therapy<br/>Bile--metabolism<br/>Cytosol--enzymology<br/>Etiocholanolone--biosynthesis<br/>Female<br/>Hypolipidemic Agents--pharmacology<br/>Hypophysectomy<br/>Liver--drug effects<br/>Microsomes, Liver--enzymology<br/>Oxidoreductases--metabolism<br/>Rats